Vikram Bhise, MD

Division Director, Child Neurology and Professor of Pediatrics

Department(s) Pediatrics

Bio Summary

Dr. Vikram Bhise, MD, is Professor of Pediatrics and Neurology at Rutgers Robert Wood Johnson Medical School and serves as Division Chief of Child Neurology and Neurodevelopmental Disabilities. He received his BA from Drew University and his MD from UMDNJ–Robert Wood Johnson Medical School, followed by residency training in Pediatrics at Maimonides Medical Center. He completed fellowships in Child Neurology at Montefiore Medical Center, Clinical Neurophysiology at SUNY Downstate, and Neuroimmunology at SUNY Stony Brook. Dr. Bhise’s clinical and academic work focuses on pediatric neurological disorders, particularly multiple sclerosis, epilepsy, and other neuroimmunologic diseases. He has received research funding from the National Multiple Sclerosis Society and other foundations and has contributed extensively to the literature on pediatric MS, epilepsy, and neuroimmunology.

Education & Training

A. UNDERGRADUATE EDUCATION:
Drew University
Madison, NJ
09/1994 – 05/1998
Degree Obtained: BA

B. GRADUATE EDUCATION:
UMDNJ-Robert Wood Johnson Medical School
New Brunswick, NJ
08/1998 - 05/2003
Degree Obtained: MD

C. POSTGRADUATE TRAINING:

Pediatrics Internship and Residency
Maimonides Medical Center
Brooklyn, NY
07/2003 - 06/2005

Child Neurology Fellowship
Montefiore Medical Center
Bronx, NY
07/2005 - 06/2008

Clinical Neurophysiology Fellowship
SUNY Downstate Medical Center
Brooklyn, NY
07/2008 - 06/2009

Neuroimmunology Fellowship
SUNY Stony Brook Medical Center
Stony Brook, NY
07/2009 - 06/2010

Research Interests

Dr. Bhise’s research centers on pediatric neuroimmunologic disorders, with a particular focus on multiple sclerosis and related demyelinating diseases. His work integrates clinical research with emerging bioinformatics and AI/ML approaches, including the use of multi-omics data to improve diagnosis, prognostication, and personalized treatment strategies in rare neurological diseases.

Publications

Ji-Sun Kim, Shawen Ilaria, Jasdeep Hundal, Vikram Bhise. Coffin-Lowry Syndrome: A Case of Clinical Convergence for Psychology, Neuropsychology, Psychiatry, Genetics, and Neurology. J Child Neurol. 2025 Aug;40(5):374-378.

Flannery KP, Safwat S, Matsell E, Battula N, Hamed AAA, Mohamed IN, Elseed MA, Koko M, Abubaker R, Abozar F, Elsayed LEO, Bhise V, Molday RS, Salih MA, Yahia A, Manzini MC. A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of ATP8A2-related disorders caused by missense changes. Neurogenetics. 2024 Oct;25(4):425-433.

Bethany Murphy, Julissa Veras, Sindhura Kolli, Brielle Formanowski, Patricia Greenberg, Lawrence Kleinman, Amisha Malhotra, Vikram Bhise. Seroprevalence of Lyme disease in children with facial nerve palsy. J Child Neurol. 2024 Aug;39(9-10):310-316.

Veras J, Thoby E, Nallapati S, Jimenez M, Bhise V. No One Really Plans to Have Multiple Sclerosis: Transition Readiness and Quality of Life in Pediatric Multiple Sclerosis. Child: Care, Health and Development, 2024 Jul; 50:e13304. https://doi.org/10.1111/cch.13304

Mackenzie Henderson, Daniel B Horton, Vikram Bhise, Gian Pal, Greta Bushnell, Chintan V Dave
Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among US Adults and Children, 2001 Through 2020. JAMA Neurol. 2023 Aug;80(8)860-867.

Vikram Bhise, Michael Waltz, T. Charles Casper, Gregory Aaen, Leslie Benson, Tanuja Chitnis, Mark Gorman, Manu S. Goyal, Yolanda Wheeler, Timothy Lotze, Soe Mar, Mary Rensel, Aaron Abrams, Moses Rodriguez, John Rose, Teri Schreiner, Nikita Shukla, Emmanuelle Waubant, Bianca Weinstock-Guttman, Jayne Ness, Jan Mendelt-Tillema. Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort. Multiple Sclerosis and Related Disorders. 2023 Mar; 71.

Yisha Cheng, Dalya Chefitz, Vikram Bhise. Never too late to treat NMDAR Encephalitis - a Pediatric Case Report and Review of Literature. European Medical Journal. 2022; 10(1):88-93.

Vikram Bhise, Suhayl Dhib-Jalbut. Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives. Neurotherapeutics. 2021 Jan;18(1)244-251.

Honors & Awards